<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Skin and Venereal Diseases</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Skin and Venereal Diseases</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский журнал кожных и венерических болезней</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1560-9588</issn><issn publication-format="electronic">2412-9097</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">36939</article-id><article-id pub-id-type="doi">10.17816/dv36939</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Benign cutaneous lymphoplasia developing at the site of tattoo</article-title><trans-title-group xml:lang="ru"><trans-title>Доброкачественная лимфоплазия кожи, развившаяся на месте татуировки</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Olisova</surname><given-names>Olga Yu.</given-names></name><name xml:lang="ru"><surname>Олисова</surname><given-names>Ольга Юрьевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра кожных и венерических болезней; доктор медицинских наук, профессор</p></bio><email>olisovaolga@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Teplyuk</surname><given-names>N. P</given-names></name><name xml:lang="ru"><surname>Теплюк</surname><given-names>Наталья Павловна</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра кожных и венерических болезней; доктор медицинских наук, профессор</p></bio><email>Teplyukn@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Garanyan</surname><given-names>Lusine G.</given-names></name><name xml:lang="ru"><surname>Гаранян</surname><given-names>Лусинэ Гарегиновна</given-names></name></name-alternatives><bio xml:lang="en"><p>MD, PhD, clinical intern</p></bio><bio xml:lang="ru"><p>Кафедра кожных и венерических болезней; клинический ординатор</p></bio><email>lusine90@list.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pyatilova</surname><given-names>P. M</given-names></name><name xml:lang="ru"><surname>Пятилова</surname><given-names>Полина Михайловна</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кафедра кожных и венерических болезней; клинический ординатор</p></bio><email>pypolina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I.M. Setchenov First Moscow State Medical University</institution></aff><aff><institution xml:lang="ru">ГБОУ ВПО Первый московский государственный медицинский университет им. И.М. Сеченова Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2015-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2015</year></pub-date><volume>18</volume><issue>2</issue><issue-title xml:lang="en">VOL 18, NO2 (2015)</issue-title><issue-title xml:lang="ru">ТОМ 18, №2 (2015)</issue-title><fpage>23</fpage><lpage>26</lpage><history><date date-type="received" iso-8601-date="2020-07-21"><day>21</day><month>07</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2015, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2015, ООО "Эко-Вектор"</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">ООО "Эко-Вектор"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://rjsvd.com/1560-9588/article/view/36939">https://rjsvd.com/1560-9588/article/view/36939</self-uri><abstract xml:lang="en"><p>Relevant published data and a clinical case with benign cutaneous lymphoid hyperplasia at the site of a multicolor tattoo are presented. The clinical picture and the diagnosis carried out by standard and noninvasive methods are described in detail. Benign cutaneous lymphoplasia was effectively treated by injections of betamethasone (diprospan) suspension into the focus.</p></abstract><trans-abstract xml:lang="ru"><p>Представлены анализ литературы и описание собственного наблюдения доброкачественной лимфоплазии кожи на месте татуировки. Подробно описана клиническая картина и диагностика с использованием как стандартных, так и неинвазивных методов исследования. Сообщается об успешном лечении доброкачественной лимфоплазии методом внутриочагового введения суспензии бетаметазона (дипроспан).</p></trans-abstract><kwd-group xml:lang="en"><kwd>benign lymphoplasia</kwd><kwd>tattoo</kwd><kwd>systemic glucocorticosteroids</kwd><kwd>diprospan</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>доброкачественная лимфоплазия</kwd><kwd>татуировка</kwd><kwd>системные глюкокортикостероиды</kwd><kwd>дипроспан</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Gardair Bouchy C., Kerdraon R., Kluger N., Armingaud P., Wakosa A., Esteve E. Cutaneous lymphoid hyperplasia (pseudolymphoma) on the red dye of a tattoo. Ann. Pathol. 2013; 33(4): 273-7. doi: 10.1016/j.annpat.2013.04.005.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Kuo W.E., Richwine E.E., Sheehan D.J. Pseudolymphomatous and lichenoid reaction to a red tattoo: a case report. Cutis. 2011; 87(2): 89-92.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Cerroni L., Borroni R.G., Massone C., Chott A., Kerl H. Cutaneous B-cell pseudolymphoma at the site of vaccination. Am. J. Dermatopathol. 2007; 29(6): 538-42.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Porto D.A., Comfere N.I., Myers L.M., Abbott J.J. Pseudolymphomatous reaction to varicella zoster virus vaccination: role of viral in situ hybridization. J. Cutan. Pathol. 2010; 37(10): 1098-102. doi: 10.1111/j.1600-0560.2009.01461.x.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Bergman R. Pseudolymphoma and cutaneous lymphoma: facts and controversies. Clin. Dermatol. 2010; 28(5): 568-74. doi:10.1016/j.clindermatol.2010.04.005.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Sangueza O.P., Yadav S., Write C.R. Jr., Braziel R.M. Evolution of B-cell lymphoma from pseudolymphoma. A multidisciplinary approach using histology, immunohistochemistry, and Southern blot analysis. J. Am. Acad. Dermatol. 1992; 14(5): 408-13.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Сергеев Ю.В. Доброкачественная лимфоплазия кожи (новое в клинике, морфологии и лечении): Автореф. дис.. канд. мед. наук. М.; 1982.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Cruz F.A., Lage D., Frigerio R.M., Zaniboni M.C., Arruda L.H. Reactions to the different pigments in tattoos: a report of two cases. An Bras. Dermatol. 2010; 85(5): 708-11.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Pham-Ledard A., Vergier B., Doutre M.S., Beylot-Barry M. Disseminated cutaneous lymphoid hyperplasia of 12 years duration triggered by vaccination. Dermatology. 2010; 220(2): 176-9. doi: 10.1159/000269845.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Martin S.J., Duvic M. Treatment of cutaneous lymphoid hyperplasia with the monoclonal anti-CD20 antibody rituximab. Clin. Lymphoma Myeloma Leuk. 2011; 11(3): 286-8. doi: 10.1016/j.clml.2011.03.017.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Roo E., Villegas C., Lopez-Bran E., Jimenez E., Valle P., Sanchez-Yus E. Postzoster cutaneous pseudolymphoma. Arch. Dermatol. 1994; 130(5): 661-3.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Zinberg M., Heilman E., Glickman F. Cutaneous pseudolymphoma resulting from a tattoo. J. Dermatol. Surg. Oncol. 1982; 8(11): 955-8.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Ильин И.И., Пасечник В.А. О лечении солитарных лимфоцитом. В cборнике тезисов 5-й научно-практической конференции НИИ косметологии Минздрава РСФСР. М.; 1972.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>O’Neill J., Fien S., Zeitouni N.C. AlA-PDT for the treatment of cutaneous pseudolymphoma: a case report. J. Drugs Dermatol. 2010; 9(6): 688-9.</mixed-citation></ref></ref-list></back></article>
